Skip to Content
  • 1.1
    Impact Factor
  • 1.3
    CiteScore
  • 22 days
    Submission to First Decision
  • 3 days
    Acceptance to Publication

Journal of Vascular Diseases

Journal of Vascular Diseases is an international, peer-reviewed, open access journal on all aspects of cardiovascular, cerebrovascular, and peripheral vascular diseases, published bimonthly online by MDPI.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (188)

  • Review
  • Open Access

Clinically significant thrombosis of surgical and transcatheter biological valves is increasingly recognised, yet most reviews have concentrated on subclinical leaflet thrombosis after transcatheter aortic valve implantation. This narrative review examines treatment and outcomes after diagnosis of clinical bioprosthetic valve thrombosis in the aortic or mitral position, keeping asymptomatic hypoattenuated leaflet thickening separate. The evidence consists of 17 observational cohorts and case series, several of which overlap, include right-sided valves or use treatment response as part of the diagnosis; no randomised treatment trial has been reported. After anticoagulation, mainly with vitamin K antagonists, most studies reported haemodynamic improvement in most patients assessed, but endpoints and denominators varied; in one transcatheter registry, complete resolution was reported in 12 of 26 patients (46%), a figure that included two patients who were not anticoagulated. Recovery often took several months. Recurrence and bleeding estimates come mainly from one mixed-valve cohort that included right-sided prostheses: thrombosis recurred in 23% of initial responders, and major bleeding occurred in 12% of treated patients versus 2% of matched controls, an observational difference that cannot be attributed wholly to anticoagulation. Evidence for thrombolysis, redo surgery and transcatheter reintervention is limited to small series and case reports. The evidence supports confirming suspected thrombosis with transoesophageal echocardiography or four-dimensional computed tomography, starting a vitamin K antagonist in haemodynamically stable patients, referring unstable patients or those with persistent obstruction for a Heart Team decision, and individualising extended anticoagulation against bleeding risk. Direct oral anticoagulants are not established for clinical thrombosis, and the optimal duration of treatment is unknown.

J. Vasc. Dis.

12 November 2026

The proposed management framework for suspected bioprosthetic valve thrombosis, derived from the reviewed evidence and current guidelines. The boxes with a solid blue outline and the label ‘ESC/EACTS 2025’ indicate steps supported by the 2025 ESC/EACTS guidelines [12]; the boxes with a dashed orange outline and the label ‘Author-proposed’ indicate review intervals, response thresholds and treatment durations proposed by the author, which are not guideline criteria and have not been validated. Haemodynamic valve deterioration, defined as a rise in mean gradient, with a fall in effective orifice area or Doppler velocity index, from the post-implantation baseline [6], places a patient with leaflet thickening or reduced motion in the clinical branch even without symptoms. An elevated gradient without a documented rise from baseline, as with patient–prosthesis mismatch or a high-flow state, does not, and such a patient is managed in the subclinical branch unless symptoms or embolism are present. The asterisk (*) in the subclinical branch denotes an elevated gradient without a documented rise from the post-implant baseline, which is explained in the box marked * below it. When no baseline study is available, classification relies on valve-specific reference values, assessment of flow, TEE or CT and serial echocardiography. Response: a fall in the mean gradient of at least 50% or a return towards the post-implant baseline, with improved leaflet mobility on echocardiography or CT. Partial response: a fall of 25% to 49%, for which anticoagulation is continued, anticoagulation control and adherence are reviewed, and imaging is repeated. Persistent obstruction: a fall of less than 25% or unchanged leaflet immobility. Options for unstable patients and for persistent obstruction are supported by very limited evidence in biological valves, and the suggested minimum duration of anticoagulation is not based on comparative evidence. 4D, four-dimensional; CT, computed tomography; DOAC, direct oral anticoagulant; HALT, hypoattenuated leaflet thickening; INR, international normalised ratio; RLM, reduced leaflet motion; TAV, transcatheter aortic valve; TAVI, transcatheter aortic valve implantation; TEE, transoesophageal echocardiography; TTE, transthoracic echocardiography; VKA, vitamin K antagonist.
  • Review
  • Open Access

Artificial intelligence (AI) is increasingly integrated into acute stroke imaging, offering new opportunities for automated image interpretation, diagnostic support, and workflow optimization. However, understanding its clinical value requires distinguishing the underlying computational methods from their diagnostic applications and demonstrated effects on patient care. This narrative educational review introduces the fundamental principles of machine learning, deep learning, and computer vision, with particular emphasis on convolutional neural networks and their applications in cerebrovascular imaging. Current evidence is examined across intracranial hemorrhage detection and volumetry, recognition of early ischemic changes, automated Alberta Stroke Program Early CT Score (ASPECTS) assessment, arterial occlusion detection, cerebral perfusion analysis, and ischemic lesion segmentation. Emerging applications in stroke etiology assessment are also discussed. Particular attention is given to persistent diagnostic challenges involving acute lacunar infarcts and cerebral small vessel disease, where conventional imaging limitations and insufficient external validation constrain current AI approaches. The review also examines generalizability, workflow integration, and regulatory considerations. AI can assist selected diagnostic tasks, but its clinical usefulness depends on external validation, appropriate implementation, and evidence of patient benefit.

J. Vasc. Dis.

11 November 2026

Conceptual relationships among artificial intelligence, machine learning, deep learning, and computer vision. (A) Artificial intelligence (AI) encompasses machine learning (ML), which learns patterns from data, and deep learning (DL), a subset of ML based on multilayer neural networks. Computer vision (CV) concerns the analysis of visual information using conventional image processing, ML, or DL methods. Panel (B) illustrates four tasks addressed by image analysis, namely identification, localization, delineation, and quantification.
  • Article
  • Open Access

Background: Deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and atherosclerosis have traditionally been regarded as distinct conditions, although they may share mechanisms involving inflammation and endothelial dysfunction. Objective: To explore the relationship between DVT, CVI, inflammatory biomarkers, and carotid plaque burden using machine learning. Methods: We included 10 patients with DVT (>1 year after diagnosis), 10 with CVI, and 10 age-, sex-, and cardiovascular risk factor- frequency-matched controls. Circulating endothelial cells (CEC), ICAM-1, CXCL7, and high-sensitivity C-reactive protein (hs-CRP) were measured. Participants underwent carotid magnetic resonance imaging, with plaques classified according to the American Heart Association (AHA) score. Kernel principal component analysis (kPCA) was followed by k-nearest neighbors (kNN) (k = 3). Results: Only ICAM-1 differed significantly between clinical groups (median [IQR]: controls, 0.41 [0.37–0.43]; DVT, 0.70 [0.61–0.79]; CVI, 0.64 [0.61–0.79] pg/mL; p < 0.001). kPCA followed by kNN identified three classes: Class 1 included 9 controls; Class 2 included 8 CVI participants and 1 control; and Class 3 included 10 DVT and 2 CVI. The prevalence of AHA plaque scores ≥3 was descriptively higher in Classes 2 and 3 than in Class 1 (77.8%, 83.3%, and 33.3%, respectively), although the overall difference did not reach statistical significance (p = 0.071). Conclusions: ICAM-1 was the only biomarker differing significantly between clinical groups. Exploratory kPCA and kNN analyses identified multidimensional patterns associated with DVT and CVI. Differences in the prevalence of AHA plaque scores ≥3 across kNN classes did not reach statistical significance. These findings are hypothesis-generating and require validation in larger cohorts.

J. Vasc. Dis.

9 November 2026

Inflammatory markers by groups: (A) Circulating endothelial cells (CEC); (B) high-sensitivity C-reactive protein (hs-CRP); (C) ICAM-1; and (D) CXCL7, p-values are shown.
  • Article
  • Open Access

Background: The reported postoperative recurrence rates of lower limb varicose veins differ considerably across studies, ranging from 7% to 62%. This study aimed to characterize the clinical and imaging findings in patients presenting with recurrent varicose veins (RVVs) and to describe short-term clinical outcomes after individualized reintervention. Methods: We enrolled 99 patients (114 lower extremities) with RVVs admitted from January 2018 to June 2025. All patients underwent duplex ultrasound scanning; computed tomography venography or magnetic resonance venography was performed to assess iliac vein anatomy. We analyzed the charts of patients for the prevalence of imaging and clinical abnormalities among patients with RVVs. This study was designed as a descriptive retrospective case series without a non-recurrent control group. We analyzed the distribution of venous abnormalities among the included limbs. Results: The mean patient age was 63.9 ± 9.8 years, and 71.7% of the patients were female. Among the 114 affected limbs, residual great saphenous vein trunks were identified in 55 (48.3%), deep venous reflux in 47 (41.2%), incompetent perforating veins in 7 (6.1%), anterior accessory great saphenous vein reflux in 2 (1.8%), and small saphenous vein reflux in 2 (1.8%). Iliac vein stenosis was suspected in 42 limbs, of which 38 underwent digital subtraction angiography; nonthrombotic iliac vein compression lesions were confirmed in 31 limbs. Confirmed lesions were more frequent in left-sided than right-sided RVVs limbs (35.8% vs. 16.3%; p = 0.03). The median venous clinical severity score decreased from 7 (interquartile range, 5–10) at admission to 2 (interquartile range, 2–3) 6 months after discharge (p < 0.01). All 20 active venous ulcers healed during follow-up. Conclusions: Residual great saphenous vein trunks, deep venous valve insufficiency, and nonthrombotic iliac vein compression lesions were frequently observed venous abnormalities in this retrospective descriptive case series of patients with RVVs. Comprehensive multimodal venous imaging may assist individualized reintervention planning. These findings describe a referred recurrent case series and cannot be interpreted as risk factors for recurrence without a non-recurrent control group. Long-term outcomes require further investigation.

J. Vasc. Dis.

28 October 2026

Examination images of a 56-year-old woman with RVVs showing an incompetent perforating vein in the area of the right femoral vein. (A) An incompetent perforating vein in the area of the right femoral vein (yellow arrow) was identified in the magnetic resonance venography image. (B) The two-dimensional ultrasound image showed the incompetent perforating vein (blue arrow) in the area of the femoral vein. (C) The color Doppler flow image showed the incompetent perforating vein (purple arrow) in the area of the femoral vein. (D) The intraoperative photo in this patient showed an incompetent perforating vein (green arrow) in the area of the femoral vein.

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
J. Vasc. Dis. - ISSN 2813-2475